selected publications
- BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 2023 Academic Article GET IT
- Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors. Frontiers in immunology. 2022 Academic Article GET IT
-
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation.
Cell reports.
2022
Academic Article
GET IT
Times cited: 1 -
Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations.
Current opinion in genetics & development.
2022
Review
GET IT
Times cited: 2 -
Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms.
Frontiers in cell and developmental biology.
2022
Academic Article
GET IT
Times cited: 62 -
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Advanced materials (Deerfield Beach, Fla.).
2021
Academic Article
GET IT
Times cited: 16 -
OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.
Nature immunology.
2021
Academic Article
GET IT
Times cited: 4 -
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.
Journal of virology.
2021
Academic Article
GET IT
Times cited: 32 -
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
Nature immunology.
2021
Academic Article
GET IT
Times cited: 17 -
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
Nature.
2020
Academic Article
GET IT
Times cited: 95 -
Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.
Molecular cell.
2020
Academic Article
GET IT
Times cited: 15 -
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Cancer cell.
2019
Article
GET IT
Times cited: 17 -
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Cancer cell.
2019
Academic Article
GET IT
Times cited: 46 -
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response.
Nature communications.
2019
Academic Article
GET IT
Times cited: 62 -
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis.
Nature immunology.
2018
Academic Article
GET IT
Times cited: 53 -
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
Cancer discovery.
2018
Academic Article
GET IT
Times cited: 101 -
Widespread Mitotic Bookmarking by Histone Marks and Transcription Factors in Pluripotent Stem Cells.
Cell reports.
2017
Academic Article
GET IT
Times cited: 78 -
Regulatory elements in molecular networks.
Wiley interdisciplinary reviews. Systems biology and medicine.
2017
Review
GET IT
Times cited: 14 -
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
Cancer discovery.
2016
Academic Article
GET IT
Times cited: 181 -
The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.
Journal of the National Cancer Institute.
2014
Academic Article
GET IT
Times cited: 104 -
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2013
Academic Article
GET IT
Times cited: 520 -
Stat3 mediates expression of autotaxin in breast cancer.
PloS one.
2011
Academic Article
GET IT
Times cited: 59 -
18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2010
Academic Article
GET IT
Times cited: 88 -
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.
Oncogene.
2006
Academic Article
GET IT
Times cited: 459